Pascal and Francis Bibliographic Databases



Selection :

Permanent link

Randomized trial of an allogeneic Melanoma lysate vaccine with low-dose interferon alfa-2b compared with high-dose interferon alfa-2b for resected stage III cutaneous melanoma

MITCHELL, Malcolm S; ABRAMS, Judith; JAKOWATZ, James G; DAS GUPTA, Tapas K; RICHARDS, Jon M; SAMLOWSKI, Wolfram E; COSTANZI, John J; ARONSON, Frederick R; DEISSEROTH, Albert B; DUDEK, Arkadiusz Z; JONES, Vicky E; THOMPSON, John A; KASHANI-SABET, Mohammed; DECONTI, Ronald C; HWU, Wen-Jen; ATKINS, Michael B; WHITMAN, Eric; ERNSTOFF, Marc S; HALUSKA, Frank G
[1] University of California, San Diego, School of Medicine and Cancer Center, San Diego, United States
[2] University of California, San Francisco, United States
[3] School of Medicine and Cancer Center, San Francisco, United States
[4] University of California, Irvine Medical School and Cancer Center, Irvine, CA, United States
[5] Karmanos Cancer Institute, Wayne State University, Detroit, United States
[6] Van Elslander Cancer Center, St John Medical Center, Grosse Pointe Woods, MI, United States
[7] University of Washington School of Medicine, Seattle, WA, United States
[8] Moffitt Cancer Center, University of South Florida, Tampa, FL, United States
[9] Yale Comprehensive Cancer Center, New Haven, CT, United States
[10] Beth Israel Medical Center, Harvard Medical School, Massachusetts, United States
[11] General Hospital Cancer Center, Harvard Medical School, Boston, MA, United States
[12] The Melanoma Center of St. Louis, St Louis, MO, France
[13] Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Hanover, NH, United States
[14] University of Illinois at Chicago, Chicago, United States
[15] Oncology Specialists, Park Ridge, IL, United States
[16] Huntsman Cancer Center, University of Utah, Salt Lake City, UT, United States
[17] Lone Star Oncology, Austin, TX, United States
[18] Maine Center for Cancer Medicine, Scarborough, ME, Canada
[19] University of Minnesota, Minneapolis, MN, United States
[20] Karmanos Cancer Institute, United States

Journal of clinical oncology. 2007, Vol 25, Num 15, pp 2078-2085, 8 p ; ref : 28 ref

Scientific domain
Medical oncology
Lippincott Williams & Wilkins, Baltimore, MD
Publication country
United States
Document type
Keyword (fr)
Cancérologie Dose faible Dose forte Essai clinique Etude comparative Interféron alpha Lysat Mélanome malin Randomisation Stade avancé Vaccin Cancer de la peau Interféron alfa Peau pathologie Tumeur maligne
Keyword (en)
Cancerology Low dose High dose Clinical trial Comparative study Alpha interferon Lysate Malignant melanoma Randomization Advanced stage Vaccine Skin cancer Interferon alfa Skin disease Malignant tumor
Keyword (es)
Cancerología Dosis débil Dosis fuerte Ensayo clínico Estudio comparativo Interferón alfa Lisado Melanoma maligno Aleatorización Estadio avanzado Vacuna Cáncer de piel Interferón alfa Piel patología Tumor maligno
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

002 Biological and medical sciences / 002B Medical sciences / 002B08 Dermatology / 002B08A Tumors of the skin and soft tissue. Premalignant lesions

Dermatology Tumours
INIST identifier

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web